Genomics In Cancer Care Market Size, Share, Trends, Growth Outlook

Genomics In Cancer Care Market is estimated to increase at a growth rate of 15.3% CAGR over the forecast period from 2024 to 2030.

The Genomics In Cancer Care Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product (Instruments, Consumables, Services), By Application (Diagnostics, Personalized medicine, Drug discovery & development, Research), By Technology (Genome sequencing, PCR, Microarrays, Nucleic acid extraction & purification, Others).

An Introduction to Genomics In Cancer Care Market in 2024

The Genomics in Cancer Care market in 2024 addresses the demand for genomic testing, precision oncology services, and targeted therapies aimed at improving cancer diagnosis, treatment selection, and patient outcomes through personalized medicine approaches. Genomics in cancer care encompasses a range of genomic technologies such as next-generation sequencing (NGS), liquid biopsy, and molecular profiling, enabling the identification of genetic mutations, tumor biomarkers, and therapeutic targets associated with various cancer types. Market dynamics are driven by factors such as the increasing adoption of precision oncology and molecular diagnostics, advancements in cancer genomics research and bioinformatics, and the demand for tailored treatment strategies and immunotherapies for cancer patients. Collaboration between oncologists, molecular pathologists, genetic counselors, and pharmaceutical companies drives innovation and market growth in genomics-based cancer care, supporting improved survival rates, treatment response, and quality of life for individuals diagnosed with cancer.

Genomics In Cancer Care Market Trend: Integration of Genomic Data into Cancer Diagnosis and Treatment

A prominent trend in the genomics in cancer care market is the integration of genomic data into cancer diagnosis and treatment. Genomic technologies such as next-generation sequencing (NGS) have enabled comprehensive analysis of tumor genomes, allowing for the identification of genetic alterations and biomarkers that can inform personalized treatment decisions. Oncologists are increasingly incorporating genomic profiling into cancer care pathways to guide treatment selection, predict drug response, and monitor disease progression. This trend is driven by the growing understanding of the molecular mechanisms underlying cancer, advancements in genomic research, and the increasing availability of targeted therapies and immunotherapies that can be tailored to specific genomic alterations, leading to improved outcomes for cancer patients.

Genomics In Cancer Care Market Driver: Demand for Personalized Medicine and Targeted Therapies

A key driver in the genomics in cancer care market is the demand for personalized medicine and targeted therapies. Traditional cancer treatments such as chemotherapy and radiation therapy have limitations in terms of efficacy and tolerability, leading to a growing interest in precision oncology approaches that aim to match patients with therapies based on their individual genetic makeup and tumor characteristics. As cancer care evolves towards a personalized approach, there is a rising demand for genomic testing services, companion diagnostics, and targeted cancer therapies that can improve treatment outcomes, minimize toxicity, and prolong survival for cancer patients. This driver is supported by advancements in cancer genomics, biomarker discovery, and drug development, as well as the increasing adoption of value-based care models that prioritize personalized treatment strategies and patient-centered care.

Genomics In Cancer Care Market Opportunity: Expansion of Genomic Testing Services and Companion Diagnostics

An opportunity for growth in the genomics in cancer care market lies in the expansion of genomic testing services and companion diagnostics. With the growing importance of genomic profiling in cancer diagnosis and treatment decision-making, there is a need for expanded access to high-quality genomic testing services that can provide accurate and actionable insights to clinicians and patients. Additionally, companion diagnostics play a critical role in identifying patients who are most likely to benefit from targeted therapies and immunotherapies, facilitating precision medicine approaches in oncology. By expanding their portfolio of genomic testing services and companion diagnostics, diagnostic companies and laboratories can capitalize on the increasing demand for personalized cancer care, establish partnerships with pharmaceutical companies developing targeted therapies, and position themselves as key players in the genomics-driven paradigm of cancer care.

Genomics In Cancer Care Market Segmentation

By product
Instruments
Consumables
Services
By Application
Diagnostics
Personalized medicine
Drug discovery & development
Research
By technology
Genome sequencing
PCR
Microarrays
Nucleic acid extraction & purification
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

 

Genomics In Cancer Care Market Companies

Agilent Technologies Inc
Bio-Rad Laboratories Inc
Cancer Genetics Inc
F. Hoffmann-La Roche AG
GE Healthcare
Illumina Inc
Intrexon Bioinformatics Germany GmbH
Luminex Corp
Merck KGaA
Myriad Genetics Inc
Pacific Biosciences of California Inc
Perkin Elmer
Qiagen NV
Quest Diagnostics
ThermoFisher Scientific Inc

 

 

Reasons to Buy the Genomics In Cancer Care Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Genomics In Cancer Care Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Genomics In Cancer Care Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

 

TABLE OF CONTENTS

1 Introduction to 2024 Genomics In Cancer Care Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Genomics In Cancer Care Market Size Outlook, $ Million, 2021 to 2030
3.2 Genomics In Cancer Care Market Outlook by Type, $ Million, 2021 to 2030
3.3 Genomics In Cancer Care Market Outlook by Product, $ Million, 2021 to 2030
3.4 Genomics In Cancer Care Market Outlook by Application, $ Million, 2021 to 2030
3.5 Genomics In Cancer Care Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Genomics In Cancer Care Market Industry
4.2 Key Market Trends in Genomics In Cancer Care Market Industry
4.3 Potential Opportunities in Genomics In Cancer Care Market Industry
4.4 Key Challenges in Genomics In Cancer Care Market Industry

5 Market Factor Analysis
5.1 Competitive Landscape
5.1.1 Global Genomics In Cancer Care Market Share by Company (%), 2023
5.1.2 Product Offerings by Company
5.2 Porter’s Five Forces Analysis

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Genomics In Cancer Care Market Outlook By Segments
7.1 Genomics In Cancer Care Market Outlook by Segments
By product
Instruments
Consumables
Services
By Application
Diagnostics
Personalized medicine
Drug discovery & development
Research
By technology
Genome sequencing
PCR
Microarrays
Nucleic acid extraction & purification
Others

8 North America Genomics In Cancer Care Market Analysis And Outlook To 2030
8.1 Introduction to North America Genomics In Cancer Care Markets in 2024
8.2 North America Genomics In Cancer Care Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Genomics In Cancer Care Market size Outlook by Segments, 2021-2030
By product
Instruments
Consumables
Services
By Application
Diagnostics
Personalized medicine
Drug discovery & development
Research
By technology
Genome sequencing
PCR
Microarrays
Nucleic acid extraction & purification
Others

9 Europe Genomics In Cancer Care Market Analysis And Outlook To 2030
9.1 Introduction to Europe Genomics In Cancer Care Markets in 2024
9.2 Europe Genomics In Cancer Care Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Genomics In Cancer Care Market Size Outlook By Segments, 2021-2030
By product
Instruments
Consumables
Services
By Application
Diagnostics
Personalized medicine
Drug discovery & development
Research
By technology
Genome sequencing
PCR
Microarrays
Nucleic acid extraction & purification
Others

10 Asia Pacific Genomics In Cancer Care Market Analysis And Outlook To 2030
10.1 Introduction to Asia Pacific Genomics In Cancer Care Markets in 2024
10.2 Asia Pacific Genomics In Cancer Care Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Genomics In Cancer Care Market size Outlook by Segments, 2021-2030
By product
Instruments
Consumables
Services
By Application
Diagnostics
Personalized medicine
Drug discovery & development
Research
By technology
Genome sequencing
PCR
Microarrays
Nucleic acid extraction & purification
Others

11 South America Genomics In Cancer Care Market Analysis And Outlook To 2030
11.1 Introduction to South America Genomics In Cancer Care Markets in 2024
11.2 South America Genomics In Cancer Care Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Genomics In Cancer Care Market size Outlook by Segments, 2021-2030
By product
Instruments
Consumables
Services
By Application
Diagnostics
Personalized medicine
Drug discovery & development
Research
By technology
Genome sequencing
PCR
Microarrays
Nucleic acid extraction & purification
Others

12 Middle East And Africa Genomics In Cancer Care Market Analysis And Outlook To 2030
12.1 Introduction to Middle East and Africa Genomics In Cancer Care Markets in 2024
12.2 Middle East and Africa Genomics In Cancer Care Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Genomics In Cancer Care Market size Outlook by Segments, 2021-2030
By product
Instruments
Consumables
Services
By Application
Diagnostics
Personalized medicine
Drug discovery & development
Research
By technology
Genome sequencing
PCR
Microarrays
Nucleic acid extraction & purification
Others

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Agilent Technologies Inc
Bio-Rad Laboratories Inc
Cancer Genetics Inc
F. Hoffmann-La Roche AG
GE Healthcare
Illumina Inc
Intrexon Bioinformatics Germany GmbH
Luminex Corp
Merck KGaA
Myriad Genetics Inc
Pacific Biosciences of California Inc
Perkin Elmer
Qiagen NV
Quest Diagnostics
ThermoFisher Scientific Inc

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By product
Instruments
Consumables
Services
By Application
Diagnostics
Personalized medicine
Drug discovery & development
Research
By technology
Genome sequencing
PCR
Microarrays
Nucleic acid extraction & purification
Others